Mississauga, Canada

Gregory V Williams

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Microbix Biosystems Inc.. Active years: 2007.



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gregory V Williams: Innovator in Virus Recovery Processes

Introduction

Gregory V Williams is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of virology, particularly in the recovery of viruses from infected chick embryos. His innovative approach has the potential to enhance viral yield, which is crucial for various applications in research and medicine.

Latest Patents

Williams holds a patent for an improved process for the recovery of viruses from allantoic fluid of virus-infected chick embryos. This patent addresses the challenge of virus recovery associated with granular and fibrous debris in the allantoic fluid. By subjecting the virus-debris complex to increased salt concentrations, specifically 0.5 M or greater, the dissociation of the virus from the debris can be achieved, thereby increasing the overall viral yield.

Career Highlights

Gregory V Williams has dedicated his career to advancing the understanding and recovery of viruses. His work at Microbix Biosystems Inc. has positioned him as a key player in the field of virology. With a focus on innovative solutions, he continues to contribute to the scientific community through his research and patents.

Collaborations

Williams collaborates with various professionals in his field, including his coworker Kenneth Hughes. Their combined expertise fosters an environment of innovation and progress within their organization.

Conclusion

Gregory V Williams exemplifies the spirit of innovation in the field of virology. His patented process for virus recovery not only enhances viral yield but also contributes to the broader scientific community. His work at Microbix Biosystems Inc. and collaborations with colleagues like Kenneth Hughes further underscore his commitment to advancing virology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…